Henry Schein, Inc.
$85.83
+0.87 · +1.03% today
Market open · updated 12:45:29 PM ET
- High
- $85.50 10:20 AM
- Low
- $83.11 9:30 AM
Against the S&P 500 Price change through Oct 27, 2026
HSIC+11.47%
S&P 500+12.87%
HSIC+32.59%
S&P 500+12.32%
HSIC+26.86%
S&P 500+87.41%
HSIC+13.56%
S&P 500+69.55%
Key numbers
- Previous close
- $84.96
- Open
- $85.65
- Day's range
- $84.94 – $86.11
- 52-week range
- $62.32 – $92.18
- Volume
- 197,346
- Average volume
- 1.2 million
- Market value
- $9.6 billion
- Price to earnings
- 24.4last 12 months
- Earnings per share
- $3.55last 12 months
- Beta
- 0.84moves less than the market
- Dividend
- None
- 50-day average
- $86.66
- 200-day average
- $80.96
Tuesday, Nov 3, 2026, before the open.
Analyst price targets and the full financials are in the terminal.
Who Henry Schein competes with From our value chain
Henry Schein in the news
No desk stories on HSIC yet. When we write about it, the story leads this list.
- HeadlineAnalysts Estimate Henry Schein (HSIC) to Report a Decline in Earnings: What to Look Out forZacks Investment Research · October 27, 2026 at 11:01 AM ET
- HeadlineHenry Schein to Report Q3 Earnings: Here's What You Should KnowZacks Investment Research · October 27, 2026 at 10:26 AM ET
- HeadlineHenry Schein to Webcast Third Quarter 2026 Conference Call on Tuesday, November 3, 2026, at 8:00 a.m. ETBusiness Wire · October 20, 2026 at 6:30 AM ET
- HeadlineWhy Henry Schein (HSIC) is a Top Growth Stock for the Long-TermZacks Investment Research · October 19, 2026 at 10:46 AM ET
- CongressMichael McCaul sold $1,001 - $15,000 of HSICHouse filing · disclosed Jul 13, 2026
- CongressMichael McCaul sold $15,001 - $50,000 of HSICHouse filing · disclosed Feb 12, 2026
- CongressJulie Johnson sold $1,001 - $15,000 of HSICHouse filing · disclosed May 15, 2025
- CongressRob Bresnahan bought $1,001 - $15,000 of HSICHouse filing · disclosed May 8, 2025
Earnings
Next report: Tuesday, Nov 3, 2026, before the open.
Congress trades in HSIC
2 purchases and 4 sales in the latest 6 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Michael McCaulHouse · R-Texas | Sale | $1,001 - $15,000 | Jun 18, 2026 | Jul 13, 2026 |
| Michael McCaulHouse · R-Texas | Sale | $15,001 - $50,000 | Jan 9, 2026 | Feb 12, 2026 |
| Julie JohnsonHouse · D-Texas | Sale | $1,001 - $15,000 | Apr 1, 2025 | May 15, 2025 |
| Rob BresnahanHouse | Purchase | $1,001 - $15,000 | Apr 8, 2025 | May 8, 2025 |
| Gilbert CisnerosHouse · D-California | Sale | $1,001 - $15,000 | Mar 31, 2025 | Apr 8, 2025 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Nov 15, 2024 | Dec 6, 2024 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About Henry Schein
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Employees
- 25,000
- Headquarters
- Melville, New York
- Website
- henryschein.com
- Listed
- Nov 3, 1995
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.